Literature DB >> 25944634

Increasing serum transferrin to reduce tissue iron overload due to ineffective erythropoiesis.

Emanuela Tolosano1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2015        PMID： 25944634      PMCID： PMC4420202          DOI： 10.3324/haematol.2015.124966

Source DB:  PubMed          Journal:  Haematologica        ISSN： 0390-6078            Impact factor:   9.941


× No keyword cloud information.
  19 in total

Review 1.  Cellular iron uptake, trafficking and metabolism: Key molecules and mechanisms and their roles in disease.

Authors:  D J R Lane; A M Merlot; M L-H Huang; D-H Bae; P J Jansson; S Sahni; D S Kalinowski; D R Richardson
Journal:  Biochim Biophys Acta       Date:  2015-02-04

2.  Hepcidin as a therapeutic tool to limit iron overload and improve anemia in β-thalassemic mice.

Authors:  Sara Gardenghi; Pedro Ramos; Maria Franca Marongiu; Luca Melchiori; Laura Breda; Ella Guy; Kristen Muirhead; Niva Rao; Cindy N Roy; Nancy C Andrews; Elizabeta Nemeth; Antonia Follenzi; Xiuli An; Narla Mohandas; Yelena Ginzburg; Eliezer A Rachmilewitz; Patricia J Giardina; Robert W Grady; Stefano Rivella
Journal:  J Clin Invest       Date:  2010-11-22       Impact factor: 14.808

Review 3.  β-thalassemia: a model for elucidating the dynamic regulation of ineffective erythropoiesis and iron metabolism.

Authors:  Yelena Ginzburg; Stefano Rivella
Journal:  Blood       Date:  2011-07-18       Impact factor: 22.113

4.  Transferrin receptor 2 is a component of the erythropoietin receptor complex and is required for efficient erythropoiesis.

Authors:  Hana Forejtnikovà; Maud Vieillevoye; Yael Zermati; Mireille Lambert; Rosa Maria Pellegrino; Soizic Guihard; Muriel Gaudry; Clara Camaschella; Catherine Lacombe; Antonella Roetto; Patrick Mayeux; Frédérique Verdier
Journal:  Blood       Date:  2010-09-08       Impact factor: 22.113

5.  Hemopexin therapy improves cardiovascular function by preventing heme-induced endothelial toxicity in mouse models of hemolytic diseases.

Authors:  Francesca Vinchi; Lucia De Franceschi; Alessandra Ghigo; Tim Townes; James Cimino; Lorenzo Silengo; Emilio Hirsch; Fiorella Altruda; Emanuela Tolosano
Journal:  Circulation       Date:  2013-02-27       Impact factor: 29.690

Review 6.  Systemic iron homeostasis.

Authors:  Tomas Ganz
Journal:  Physiol Rev       Date:  2013-10       Impact factor: 37.312

7.  Regulation of cell surface transferrin receptor-2 by iron-dependent cleavage and release of a soluble form.

Authors:  Alessia Pagani; Maud Vieillevoye; Antonella Nai; Marco Rausa; Meriem Ladli; Catherine Lacombe; Patrick Mayeux; Frédérique Verdier; Clara Camaschella; Laura Silvestri
Journal:  Haematologica       Date:  2015-01-30       Impact factor: 9.941

Review 8.  The role of hepatic transferrin receptor 2 in the regulation of iron homeostasis in the body.

Authors:  Christal A Worthen; Caroline A Enns
Journal:  Front Pharmacol       Date:  2014-03-06       Impact factor: 5.810

Review 9.  The extrahepatic role of TFR2 in iron homeostasis.

Authors:  Laura Silvestri; Antonella Nai; Alessia Pagani; Clara Camaschella
Journal:  Front Pharmacol       Date:  2014-05-07       Impact factor: 5.810

Review 10.  Heme in pathophysiology: a matter of scavenging, metabolism and trafficking across cell membranes.

Authors:  Deborah Chiabrando; Francesca Vinchi; Veronica Fiorito; Sonia Mercurio; Emanuela Tolosano
Journal:  Front Pharmacol       Date:  2014-04-08       Impact factor: 5.810
View more
  2 in total

1.  Neomorphic effects of the neonatal anemia (Nan-Eklf) mutation contribute to deficits throughout development.

Authors:  Antanas Planutis; Li Xue; Cecelia D Trainor; Mohan Dangeti; Kevin Gillinder; Miroslawa Siatecka; Danitza Nebor; Luanne L Peters; Andrew C Perkins; James J Bieker
Journal:  Development       Date:  2017-02-01       Impact factor: 6.868

2.  Determination of cerebrospinal fluid leakage by selective deletion of transferrin glycoform using an immunochromatographic assay.

Authors:  Jusung Oh; Seok-Joon Kwon; Jonathan S Dordick; William J Sonstein; Robert J Linhardt; Min-Gon Kim
Journal:  Theranostics       Date:  2019-05-31       Impact factor: 11.556
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.